New thiosemicarbazone derivatives were tested against pathogenic yeasts and molds.
The genotoxicity of the most effective anticandidal agents was evaluated.
Each derivative was evaluated for its cytotoxicity against A549 and NIH/3T3 cells.
Compounds 1 and 3 were the most effective anticandidal derivatives.
Compound 2 was the most promising anticancer agent against A549 cell line.